NewLine: Funding, Investors & Team (Sep 2026)
NewLine researches phage feed additives to prevent livestock infections.
NewLine has raised $14.8M across 1 funding round on record, the most recent a Series A of $14.8M announced in Jul 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
NewLine Company Profile and Key Stats
Latest funding round on record: Jul 2026.
NewLine Funding Rounds
NewLine Investors
NewLine Funding Compared to Other Biotechnology Startups
NewLine's latest round of $14.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NewLine in Biotechnology and Weifang
Companies Similar to NewLine
Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET…
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic…
Salus BioMed is an innovative biomedical company that specializes in developing genetic sequencing technology…
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the…
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of…
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The…
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer…
Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
NewLine Funding FAQs
What does NewLine do?
NewLine researches phage feed additives to prevent livestock infections.
How much funding has NewLine raised?
NewLine has raised $14.8M across 1 round on record. The most recent is a Series A of $14.8M announced in Jul 2026.
When did NewLine last raise funding?
NewLine's most recent funding round on record is a Series A of $14.8M, announced in Jul 2026.
Who has invested in NewLine?
Investors on record for NewLine include Addor Capital, CMB International Capital Corporation.
Where is NewLine headquartered?
NewLine is based in Weifang, China.
How many employees does NewLine have?
NewLine is in the 101-250 employee band.
When was NewLine founded?
NewLine was founded in 2018.
How does NewLine's funding compare to other Biotechnology startups?
NewLine's latest round of $14.8M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's NewLine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NewLine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.